Biomarkers are critical in ERT epidemiology as they help to monitor disease progression, treatment response, and potential side effects. Biomarkers such as enzyme activity levels, substrate concentrations, and genetic mutations are used to diagnose diseases, guide therapy decisions, and evaluate the effectiveness of ERT. Epidemiologists analyze biomarker data to identify patterns and correlations that can inform clinical practice and public health policies.
